Skip to main content

Month: December 2020

UPM has completed employee consultation processes

(UPM, Helsinki, 2 December 2020 at 09:00 EET) – UPM has completed the employee consultation process started in October on its plans to improve efficiency in global functions. UPM increases efficiency of its global functions by reorganising and streamlining the functions’ operations in five countries. This will decrease the number of positions in the functions by 67, of which 46 in Finland.UPM has also concluded the consultations regarding the reorganisation and restructuring at the Finnish pulp mills and UPM Forest that were announced in August. The consultations led to a reduction of 80 jobs in the Finnish pulp operations and 55 in UPM Forest.UPM provides support for employees who are affected by the reductions. It includes outplacement services and training opportunities that support re-employment of the affected employees.Earlier this...

Continue reading

UPM:n yt-neuvottelut ovat päättyneet

(UPM, Helsinki, 2.12.2020 klo 09:00 EET) – UPM on saanut päätökseen lokakuussa käynnistyneet yhteistoimintaneuvottelut globaalien funktioiden toiminnan tehostamiseksi. Konsernin globaalien tukitoimintojen uudelleen järjestely ja virtaviivaistaminen viidessä maassa vähentää yhteensä 67 tehtävää, joista 46 tehtävää on Suomessa.Elokuussa ilmoitetut yhteistoimintaneuvottelut UPM:n suomalaisissa sellutehtaissa sekä Suomen metsätoiminnoissa on myös saatu päätökseen. Uudelleenjärjestelyjen seurauksena selluliiketoiminnassa päättyy 80 työpaikkaa ja UPM Metsällä 55 työpaikkaa.UPM tarjoaa tukea niille, joita henkilöstövähennykset koskettavat. Muutosturva sisältää uudelleentyöllistymiseen tähtääviä palveluita ja koulutusta.UPM on aiemmin tänä vuonna ilmoittanut useista toimenpiteistä kiinteiden ja muuttuvien kustannusten vähentämiseksi eri liiketoiminnoissaan...

Continue reading

Hexagon Purus AS: Contemplated private placement and admission to trading on Euronext Growth Oslo

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Hexagon Purus AS (the “Company” or “Hexagon Purus” or “Purus”) has engaged Carnegie AS and Skandinaviska Enskilda Banken AB (publ) as Joint Bookrunners (together the “Managers”) to advise on and effect a contemplated private placement of new shares in the Company to raise proceeds of up to NOK 750 million (the “Private Placement”), corresponding to approx. 13.6-15% of the current share capital in the Company, depending on the final price in the Private Placement.The net proceeds from the Private Placement...

Continue reading

Clariant AG: Construction of Clariant’s sunliquid® plant in Romania on track for completion by the end of 2021

Muttenz, December 2, 2020– Clariant, a focused, sustainable and innovative specialty chemical company, today announced that it is making good progress with the construction of its sunliquid® cellulosic ethanol production plant in Podari, in the southwestern part of Romania. While the COVID-19 pandemic continues to present a challenging situation, Clariant’s team was able to ensure that work on the construction site continues while fully complying with all pandemic precaution regulations as established by the Romanian authorities.“It is truly impressive to see how our project team as well as all local partners have been able to keep this important construction project running while ensuring everyone’s safety and health during the COVID-19 pandemic. Once completed, this sunliquid® cellulosic ethanol production plant will be a cornerstone...

Continue reading

Enstar schließt Verkauf und Rekapitalisierung von StarStone U.S. ab

HAMILTON, Bermuda, Dec. 02, 2020 (GLOBE NEWSWIRE) — Enstar Group Limited (NASDAQ: ESGR) („Enstar“) gab heute bekannt, dass der Verkauf und die Rekapitalisierung von StarStone U.S. Holdings, Inc. („StarStone U.S.“) durch den Verkauf von StarStone U.S an Core Specialty Insurance Holdings, Inc. („Core Specialty“) im Tausch gegen eine Kombination aus Barmitteln und etwa 25 % der Aktien von Core Specialty abgeschlossen wurden. Der Abschluss der Transaktion erfolgte nach Erhalt der aufsichtsrechtlichen Genehmigungen und der Erfüllung verschiedener anderer Abschlussbedingungen.Die Investoren von Core Specialty, darunter SkyKnight Capital, L.P., Dragoneer Investment Group, Aquiline Capital Partners LLC und weitere Investoren, überwiegend Mitglieder des Managements und Direktoren, haben neues Eigenkapital in Höhe von 610 Millionen Dollar...

Continue reading

Síminn hf. – Síminn selur Sensa ehf. til alþjóðlega upplýsingatæknifyrirtækisins Crayon Group A.S.

Síminn hf. („Síminn“) og alþjóðlega upplýsingatæknifyrirtækið Crayon Group A.S. („Crayon“) undirrituðu í dag skuldbindandi samning um sölu Símans á dótturfélaginu Sensa ehf. („Sensa“) til Crayon.Sensa hefur um árabil verið í fararbroddi íslenskra upplýsingatæknifyrirtækja og spannar starfsemi félagsins allt frá rekstri, hýsingu og skýjalausnum til sérfræðiþjónustu og ráðgjafar. Undanfarin ár hefur Sensa byggt markvisst upp þekkingu á hagnýtingu Microsoftlausna. Starfsmenn Sensa eru 115 talsins, þar af vinna 91 við ráðgjöf og upplýsingatækni.Crayon er með höfuðstöðvar í Ósló og hafa hlutabréf móðurfélags félagsins Crayon Group Holding verið tekin til viðskipta hjá Oslo Børs (kauphöllinni í Ósló). Hjá fyrirtækinu starfa um 1.700 manns en fyrirtækið er með 55 starfsstöðvar í 35 löndum, í Evrópu, Norður-Ameríku, Eyjaálfu og Asíu. Crayon er...

Continue reading

Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19

U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174; Companies are ready to deliver the first doses to the U.K. immediatelyFirst authorization for a COVID-19 vaccine represents a breakthrough scientific achievement to help combat this devastating pandemicThe companies previously signed an agreement to supply a total of 40 million doses to the U.K. with delivery in 2020 and 2021U.S. FDA and EU EMA decisions on authorization are expected in DecemberNEW YORK and MAINZ, GERMANY, December 2, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19. This constitutes the...

Continue reading

Pfizer und BioNTech erhalten weltweit erste Zulassung für COVID-19-Impfstoff

Die britische Regulierungsbehörde MHRA genehmigt die Lieferung von COVID-19-Impfstoff zur Notfallversorgung (gemäß Verordnung 174); erste Lieferungen werden innerhalb weniger Tage im Vereinigten Königreich eintreffenDiese erste Notfallzulassung für einen COVID-19-Impfstoff ist ein bahnbrechender wissenschaftlicher Meilenstein, um die Pandemie zu adressierenDie Unternehmen haben eine Vereinbarung mit dem Vereinigten Königreich zur Lieferung von insgesamt 40 Millionen Impfstoffdosen in den Jahren 2020 und 2021 getroffenDie Entscheidungen der amerikanischen FDA sowie der europäischen EMA über mögliche Zulassungen werden im Dezember erwartetNEW YORK, USA und MAINZ, Deutschland, 2. Dezember 2020 — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute bekannt, dass die Medicines & Healthcare Products Regulatory Agency (MHRA)...

Continue reading

PST Will Perform Reconstruction in Panevezys

Panevezio statybos trestas AB (PST) has signed the contract for reconstruction of the cultural building at Respublikos Str. 40, Panevezys. The total area of the building is 3746 square meters. The contract value exceeds 9 mln. Euros. The project will be completed in 20 months.More information:Managing DirectorEgidijus UrbonasTel.: (+370 45) 505 503

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.